009420.KS
Hanall Biopharma Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 53,900.00
−2.00%Leverage
- Debt / equity
- 0.28x
- Net debt / equity
- 0.09x
- Debt / assets
- 0.19x
- Debt / EBITDA
- -3.32x
- Net debt / EBITDA
- -1.09x
Liquidity & coverage
- Current ratio
- 1.49x
- Quick ratio
- 0.84x
- Cash ratio
- 0.49x
- Interest coverage
- 4.40x
- EBITDA / interest
- -15.20x
- Working capital
- KRW 30.7B
Cash & dividend
- FCF / debt
- -0.12x
- Cash flow / debt
- -0.03x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026